Evotec (OTCMKTS:EVTCY) Shares Pass Below 50 Day Moving Average - Should You Sell?

Key Points

• Evotec SE shares have fallen below their fifty-day moving average, currently trading at $3.48 after hitting a low of $3.47 during trading.
• The company has a market capitalization of $1.15 billion and a P/E ratio of 8.49, indicating its valuation in the market.
• Evotec specializes in drug discovery and development for pharmaceutical and biotechnology companies, operating through segments such as EVT Execute and EVT Innovate.

Evotec SE (OTCMKTS:EVTCY - ) shares passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.70 and traded as low as $3.47. Evotec shares last traded at $3.48, with a volume of 14,101 shares traded.

Evotec Stock Down 1.7%

The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock has a market capitalization of $1.15 billion, a P/E ratio of 8.49 and a beta of 0.98. The stock's fifty day simple moving average is $3.70 and its two-hundred day simple moving average is $3.82.

About Evotec

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.